AI-driven cytometry analysis for clinical development

Biomarker endpoints in days, not months — reproducible and trial‑ready.

Ozette provides AI systems for cytometry analysis; automating flow and spectral cytometry analysis for clinical trials — end to end, from sample to answer — so your biomarker teams get clean, reproducible endpoint results at the pace of your study, under a validated quality system.

Trusted by Cerba Research, Bloodworks Bio, and Umoja Biopharma
Born from the Gottardo Lab at Fred Hutch

app.ozette.com · Full Cell Discovery
Ozette Platform — Full Cell DiscoveryParent Cell-PopulationPhenotype FilterCD11C+CD16-Sample FilterRobust Phenotype Abundance HeatmapSelectionColorFilterReorderMetadata2.95-2.95Cell EmbeddingSample StatisticsAbundance by Visit35%30%25%20%15%10%5%0%V0V1V2V3V4V5V6V7V8V9V10V11ARM OR COHORTSAMPLE TREATMENTTREATMENTTREATMENT2SUBJECT EXT.BIOSAMPLE EXT.EXPSAMPLE EXT.FILE NAME
Live view · Full Cell Discovery
Partners & provenance Cerba Research Bloodworks Bio Umoja Biopharma Fred Hutch · Gottardo Lab
The problem we solve

Clinical biomarker analysis is the bottleneck. It shouldn't be.

Three failures slow every cytometry-driven trial. Ozette fixes all three on one platform.

01

Endless re-unmixing

Spectral data carries artifacts and autofluorescence. Teams regenerate controls and re-unmix the same files again and again.

02

Slow, biased gating

Manual gating misses rare populations and isn't reproducible across analysts, batches, or sites.

03

Results arrive too late

Analysis lands months after the data — too late to inform interim decisions, too inconsistent to trust.

The platform

One platform, three tiers — each builds on the last.

Start where your pain is sharpest and expand up the ladder. Every tier includes everything below it.

Tier 1 · Entry

Resolve

The foundation

Adaptive, cloud-native unmixing. Eliminates artifacts and manual compensation — clean data on the first pass.

Self-serve sweet spot
Tier 2

Endpoints

Includes Resolve

Automated, reproducible biomarker endpoints for clinical trials — no cap on endpoints, samples, or interim analyses.

Tier 3

Discovery

Includes both below

Unbiased annotation of every cell population — find rare and previously uncharacterized phenotypes.

Two ways to buy any tier

Run it yourself, or let us run it for you.

You drive the analysis.

Your team operates the platform directly. Buy a license and pay as you go — only for the files you process. We onboard and train you so you can run it yourself.

  • License + pay-per-file pricing
  • Free file allowance to start
  • Onboarding & training included
Best for
Teams who want control and predictable, usage-based cost.

We deliver results, not a workflow.

The Ozette Lab generates 48-color PIP-01 spectral data under GCLP and runs the analysis end-to-end. You get trial-ready results without managing the pipeline.

  • 48-color PIP-01 spectral data generation
  • GCLP-compliant, end-to-end
  • Ozette scientists run the analysis
Best for
Clinical programs that need data and insight delivered to spec.
End to end · Ozette Lab

Or have us run the whole thing.

Don't want to operate anything? The Ozette Lab generates your 48-color PIP-01 spectral data and runs the analysis — one accountable team, from sample to answer, under a validated quality system.

1
Sample receipt

Send us your samples — we handle intake and logistics.

2
Data generation

Our modular spectral assay — a 32-color backbone plus the modules your study needs, generated under GCLP.

3
ML analysis

Resolve, Endpoints, and Discovery, applied by our scientists.

4
Insights delivered

Trial-ready results and biomarkers, delivered to spec.

See the Ozette Lab →
Days
not months
48
color spectral
100%
populations annotated*
QMS
validated, GCLP
How an engagement works

From your panel to trial-ready results in three steps.

Consult

We align on your panel, pre-defined endpoints, and goals, then build a reproducible pipeline.

Run

Your validated pipeline runs on trial data automatically as it arrives — interim analyses included.

Explore

Review, approve, and export results in an interactive dashboard. Figures and summary data, ready to use.

Built for your team

Whatever you're trying to learn from the immune system.

Primary

Clinical development

Reproducible biomarker endpoints at trial scale, under a validated quality system.

Research

Discovery & R&D

Find rare and previously uncharacterized populations without manual gating.

Academic

Academic labs

The rigor of Ozette analysis, accessible to a single lab — start self-serve with Resolve.

Proof in the science

What teams have found with Ozette.

PD-1

Predicting immunotherapy response

In Merkel cell carcinoma and melanoma — benchmarked against conventional analysis.

View case study →
New

A hidden suppressive T-cell population

Revealed in the tumor microenvironment, informing immuno-oncology drug development.

View case study →
COVID

Re-analyzing published COVID-19 data

Discovery surfaced structure missed by the original manual workflow.

View case study →
Trust & compliance

The rigor your trial demands — applied to the analysis behind it.

Ozette runs under a robust quality management system that meets or exceeds applicable regulatory guidelines, with core methods proven over a decade of research.

QMSValidated quality system
GCLPLab data generation
ReproducibleLocked, consistent pipelines
CloudNative & scalable
Get started

Ready to see it on your own data?

Pick the path that fits where you are.

Clinical & product teams
Try Resolve, self-serve
Managed service & the Lab